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Small RNA profiling reveals antisense transcription
throughout the KSHV genome and novel small RNAs
YAO-TANG LIN,1 RODNEY P. KINCAID,1 DHIVYA ARASAPPAN,1 SCOT E. DOWD,2
SCOTT P. HUNICKE-SMITH,1 and CHRISTOPHER S. SULLIVAN1
1Molecular Genetics and Microbiology, The University of Texas at Austin, Austin, Texas 78712-0162, USA
2Research and Testing Laboratory, Lubbock, Texas 79407, USA
ABSTRACT
Kaposi’s sarcoma-associated herpesvirus (KSHV) is a human tumor virus that encodes 12 precursor microRNAs (pre-miRNAs)
that give rise to 17 different known ~22-nucleotide (nt) effector miRNAs. Like all herpesviruses, KSHV has two modes of
infection: (1) a latent mode whereby only a subset of viral genes are expressed and (2) a lytic mode during which the full
remaining viral genes are expressed. To date, KSHV miRNAs have been mostly identified via analysis of cells that are undergoing
latent infection. Here, we developed a method to profile small RNAs (~18–75 nt) from populations of cells undergoing
predominantly lytic infection. Using two different next-generation sequencing platforms, we cloned and sequenced both pre-
miRNAs and derivative miRNAs. Our analysis shows that the vast majority of viral and host 5p miRNAs are co-terminal with the
59 end of the cloned pre-miRNAs, consistent with both being defined by microprocessor cleavage. We report the complete
repertoire (25 total) of 5p and 3p derivative miRNAs from all 12 previously described KSHV pre-miRNAs. Two KSHV pre-
miRNAs, pre-miR-K12-8 and pre-miR-K12-12, encode abundant derivative miRNAs from the previously unreported strands of
the pre-miRNA. We identify several novel small RNAs of low abundance, including viral miRNA-offset-RNAs (moRNAs), and
antisense viral miRNAs (miRNA-AS) that are encoded antisense to previously reported KSHV pre-miRNAs. Finally, we observe
widespread antisense transcription relative to known coding sequences during lytic replication. Despite the enormous potential
to form double-stranded RNA in KSHV-infected cells, we observe no evidence for the existence of abundant viral-derived small
interfering RNAs (siRNAs).
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INTRODUCTION
Two classes of small RNAs that are effectors of RNA si-
lencing are microRNAs (miRNAs) and small interfering
RNAs (siRNAs) (for review, see Carthew and Sontheimer
2009). miRNAs have been the subject of enormous interest
due to the regulatory roles they play in numerous and dis-
parate biological processes, including viral infection (for
review, see Sullivan and Ganem 2005; Nair and Zavolan
2006; Samols and Renne 2006; Sarnow et al. 2006; Gottwein
and Cullen 2008; Grey et al. 2008; Pfeffer 2008; Sullivan
2008). miRNAs are small, z22-nucleotide (nt) RNAs that
bind to mRNAs and regulate gene expression in a post-
transcriptional manner (for review, see Bartel 2004; Kim
2005; Vasudevan et al. 2008). miRNAs are derived from
longer primary transcripts (pri-miRNAs) that can be thou-
sands of nucleotides long (Cullen 2004). pri-miRNAs con-
tain at least one z90-nt sequence that folds into a char-
acteristic hairpin secondary structure element, which is
recognized and excised by the multi-protein nuclear Mi-
croprocessor complex, giving rise to an z60-nt hairpin
called a precursor miRNA (pre-miRNA) (Bartel 2004; Kim
2005). The pre-miRNA is then exported to the cytoplasm,
whereupon it is recognized and cleaved by a complex of
proteins containing the RNase III-like protein Dicer. Dicer
cleavage results in a transient, imperfectly complementary
double-stranded z22-nt RNA, of which one strand be-
comes stably incorporated into the RNA-induced silenc-
ing complex (RISC). Typically, one strand is preferentially
retained in RISC (the guide strand), and the other strand
(the star [*] strand) is barely detectable due to degra-
dation. Once a miRNA is active within RISC, the com-
plex binds to target mRNA transcripts and affects protein
expression.
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Recently, two additional classes of small RNA derivatives
have been reported from pre-miRNA loci. microRNA-
offset-RNAs (moRNAs, or moRs) were originally described
as an abundant class of small RNAs present in the simple
chordate Ciona intestinalis, where almost 50% of all de-
scribed miRNA loci also express moRNAs (Shi et al. 2009).
moRNAs arise from the base of the pre-miRNA hairpin
stem, are z22-nt long, and are thought to be processed by
the RNAi RNase III components. moRNAs have also been
reported to exist in mammalian cells, albeit the frequency
of loci that encode them, and their absolute abundance
are considerably lower than in C. intestinalis (Langenberger
et al. 2009). Additionally, antisense miRNAs (AS-miRNAs)
have been described that derive from hairpins formed from
complementary transcripts to existing pre-miRNAs. AS-
miRNAs are not simply ‘‘noise’’ derivatives of antisense
transcription, since several studies report a role for AS-
miRNAs in regulating homeotic gene expression in Dro-
sophila and possibly mammals (Stark et al. 2008; Tyler et al.
2008). Recently, AS-miRNAs have been reported in two
herpesviruses, MCMV and HSV-1 (Buck et al. 2007; Dolken
et al. 2007; Umbach et al. 2008).
siRNAs are z21-nt RNAs that are loaded into RISC and
can also effect gene silencing. Unlike most miRNAs, siRNAs
direct a specific, irreversible cleavage of their target mRNAs.
siRNAs are thought to be RNAi effectors that guard against
invasive genetic elements such as transposons and viruses
(Ding and Voinnet 2007; Carthew and Sontheimer 2009).
Synthetic siRNAs have shown great utility as laboratory
reagents for knocking down the expression levels of par-
ticular genes of interest in mammalian cells, including viral
gene products (Elbashir et al. 2001; Gitlin et al. 2002).
While all miRNAs are generated from a single-stranded
primary transcript (with subportions folding into imperfect
double-stranded hairpins), endogenous siRNAs are gener-
ated from longer, perfectly complementary double-stranded
RNA (dsRNA) transcripts. In mammalian cells, there are
hundreds of known endogenous transcripts that code for
miRNAs; however, there are only a few clear examples of
endogenously derived siRNAs (Babiarz et al. 2008; Watanabe
et al. 2008).
So far, there have been no reports of viral-specific siRNAs
being produced during infection of mammalian cells (Cullen
2006). However, some viruses encode miRNAs within their
genomes. Viral miRNAs have been identified from viruses
with DNA genomes, including those of the Herpes, Poly-
oma, and Asco virus families (Nair and Zavolan 2006;
Samols and Renne 2006; Gottwein and Cullen 2008; Grey
et al. 2008; Hussain et al. 2008; Sullivan 2008; Sullivan and
Cullen 2009). Most viral miRNAs have been identified by
sequencing of small RNA libraries (Pfeffer et al. 2004; Cai
et al. 2005, 2006; Dunn et al. 2005; Samols et al. 2005;
Burnside et al. 2006; Dolken et al. 2007; Yao et al. 2007;
Umbach et al. 2008), but computational methods have
played a key role in the discovery of numerous viral miRNAs
(Grey et al. 2005; Pfeffer et al. 2005; Sullivan et al. 2005,
2009; Cui et al. 2006; Grundhoff et al. 2006; Buck et al.
2007; Sullivan and Grundhoff 2007; Hussain et al. 2008;
Seo et al. 2008). Viral miRNAs are capable of targeting
host- or viral-encoded transcripts, some of which have been
shown to function in various pro-viral processes such as
evading the host immune response and autoregulation of
viral gene expression (Sullivan 2008). However, the func-
tion of most of the approximately 140 known viral miRNAs
remains unknown.
Most of the known viral miRNAs derive from members
of the Herpes family. All herpesviruses undergo two char-
acteristic modes of replication, latent and lytic. During la-
tent infection, only a small subset of viral gene products is
expressed. Alternatively, the full repertoire of viral genes is
expressed during lytic infection, culminating in the pro-
duction of infectious virions and lysis of the cell. Most
herpesviral miRNAs were identified from cells that were pre-
dominantly undergoing latent infection. However, miRNAs
have been detected from viruses undergoing productive
lytic infection with HCMV, MCMV, HSV-1, HSV-2, MDV-1,
and MDV-2 viruses (Pfeffer et al. 2005; Burnside et al.
2006; Cui et al. 2006; Yao et al. 2007; Tang et al. 2008). In-
terestingly, accumulating evidence suggests that some viral
miRNAs will play a role in regulating the switch from latent
to lytic infection (Grey et al. 2007; Murphy et al. 2008;
Cullen 2009).
KSHV is a member of the gamma sublineage of the
Herpesvirus family. KSHV is the etiologic agent of rare B
cell malignancies and Kaposi’s sarcoma, a highly vascular-
ized skin lesion found in some people with immunodefi-
ciencies (for review, see Ganem 2007). Like all herpesvi-
ruses, KSHV has a large, double-stranded DNA genome
(z160 kb) (Russo et al. 1996). KSHV encodes more than
85 protein-coding genes, and at least 12 pre-miRNAs that
give rise to at least 17 different miRNAs (16 different 5p or
3p miRNAs, and a single-nucleotide-edited miRNA) that
are highly conserved (Marshall et al. 2007). The pre-miRNAs
are clustered in a single z4-kb region of the genome and
are encoded in a polycistronic fashion from any of several
different transcripts made during latent infection (Pearce
et al. 2005; Cai and Cullen 2006). Two of the pre-miRNAs
found in this cluster, pre-miR-K12-10 and pre-miR-K12-
12, are also encoded by an additional transcript that is
transactivated during lytic infection (Sullivan and Cullen
2009). Thus, all known KSHV miRNAs are expressed dur-
ing latent infection, and those miRNAs derived from pre-
miR-K12-10 and pre-miR-K12-12 have been shown, or are
expected to be further induced during lytic replication.
Detailed functional roles of the KSHV miRNAs during
bona fide infection are lacking. However, several mRNA
targets that are repressed by the KSHV miRNAs have been
identified (Gottwein et al. 2007; Samols et al. 2007; Skalsky
et al. 2007; Whitby 2009; Ziegelbauer et al. 2009). Some
of these targets include host genes that play a role in
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angiogenesis, transformation, and apoptosis, suggesting
that the KSHV miRNA may be involved in the pathogenesis
associated with KSHV infection.
Most of the KSHV pre-miRNAs (11 of 12) were orig-
inally identified by sequencing small RNA libraries from
cells predominantly undergoing latent infection (Cai et al.
2005; Pfeffer et al. 2005; Samols et al. 2005). One ex-
ception to this is that the Renne group has performed
small-scale sequencing (a few hundred total amplicons)
from a library of small RNAs obtained from TPA-treated
cells that have an elevated level of lytic infection (Samols
et al. 2005). Additionally, one of the KSHV pre-miRNAs,
pre-miR-K12-12, was not cloned, but rather was identified
by computational methods, and its derivative 5p arm was
confirmed by microarray and Northern blot analyses of
RNA isolated from cells undergoing latent infection
(Grundhoff et al. 2006). Because all of the known KSHV
miRNAs cluster within a 4-kb region of the genome that is
transcribed during latency, it is reasonable to speculate
that additional KSHV miRNAs may exist in the remain-
ing majority of the genome that is actively transcribed
during lytic infection. In addition, given that many KSHV
transcripts made during lytic replication are expressed at
high levels and have head-to-head orientations and over-
lapping regions, it is possible that lytic replication may
trigger an RNAi response that could be probed for by
mining for KSHV-specific siRNAs. So far, however, there
have been no reports that have examined in depth whether
KSHV encodes small RNAs that are specific to the lytic
cycle. Therefore, using the 454 and SOLiD platforms
(see G Hannon, ‘‘Cloning small RNAs for sequencing
with 454 technology,’’ http://genoseq.ucla.edu/images/a/
a9/SmallRNA.pdf) (Applied Biosystems 2009), we have
deep-sequenced small RNA libraries from cells that are
predominantly undergoing latent or lytic infection. Our ap-
proach involves making multiple libraries of different size
classes allowing us to systematically clone pre-miRNAs
as well as derivative miRNAs. This furthermore allows us
to identify regions of the genome that are specifically
enriched for miRNA/siRNA sizes over other (random
degradation) size classes. These studies reveal a surprising
wealth of transcription throughout the entire KSHV ge-
nome and map the entire repertoire of KSHV miRNAs
and star sequences, some of which are abundant but have
so far escaped cloning. We also systematically clone and
map the viral pre-miRNAs. In addition, we report the first
viral-encoded moRNA and KSHV-encoded AS-miRNAs.
Surprisingly, KSHV AS-miRNAs appear to be predomi-
nantly expressed during lytic infection, representing lytic-
specific KSHV miRNAs. Finally, we identify numerous
regions of the genome encoding antisense transcripts with
the potential to form dsRNAs, yet we observe no con-
vincing evidence of KSHV-specific siRNAs. The implica-
tions of these findings to the KSHV replication cycle are
discussed.
RESULTS
Small RNA profiling reveals regions of the genome
are enriched for 19–23-nt RNAs
We set out to determine if KSHV encodes siRNAs or
miRNAs specific to lytic replication. A caveat to studying
lytic replication in primary effusion lymphoma (PEL) cells
is that the process of viral replication can lead to abundant,
nonspecific, general degradation of RNA. We reasoned that
one way to differentiate regions of the KSHV genome that
were enriched for siRNAs and miRNAs over random degra-
dation fragments would be to compare the number of
KSHV 19–23 base-pair (bp) reads versus other size classes
present in the libraries for a given region of the genome
(Fig. 1B). This logic assumes that regions of the genome
that are more prone to random degradation will have in-
creases in other size classes of small RNAs, not just those
that correspond to siRNAs and miRNAs. Conversely, regions
of the genome enriched for siRNA or miRNA production
should show an increase in the ratio of 19–23-mer RNAs
over the other size classes.
For most of our experiments, we used an inducible
BCBL-1-derived cell line (TREx BCBL-RTA) developed by
Jung and colleagues (Nakamura et al. 2003). Recently, this
cell line was shown to be highly inducible into lytic repli-
cation by the addition of TPA, ionomycin, and doxycylcine
(T.I.D.) (Arias et al. 2009). The BCBL-1 cell line (and its
derivatives) is infected with KSHV and was originally
derived from PEL cells from a patient with advanced HIV
disease (Renne et al. 1996). Treatment of the TREx BCBL-
RTA cells, as previously described (Arias et al. 2009), results
in strong induction of lytic gene expression as judged by
multiple assays. Immunoblot analysis for proteins specific
to (or enriched for) lytic replication (RTA, Kaposin B, and
K8.1) shows robust induction (Fig. 1C). Northern blot
analysis shows a strong induction of the noncoding RNA
PAN (Fig. 1D), which is only expressed during lytic repli-
cation (Sun et al. 1996; Zhong et al. 1996). Finally, flow
cytometric analysis of cells for the master lytic switch pro-
tein RTA (z88% cells positive), or a marker of late gene
expression, K8.1 (z48% cells positive), clearly shows a large
enrichment in the fraction of cells that are initiating the
lytic cascade of gene expression (Fig. 1E).
We next size fractionated total RNA from the latent
population of cells or cells enriched for lytic replication. We
isolated RNA from two regions of the denaturing gel, in-
cluding RNA of z18–26 nt that should include miRNAs,
random degradation fragments, and possibly siRNAs, as
well as the RNA that is z45–75 nt in length that should
include pre-miRNAs, random degradation fragments, and
possibly other classes of noncoding RNAs (Fig. 1A). These
RNA were ligated to linkers, reverse transcribed, and sub-
jected to deep sequencing using the SOLiD platform (Ap-
plied Biosystems 2009). In addition, we examined regular
Lin et al.
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BCBL-1 cells (obtained from ATCC). Untreated BCBL-1
cells predominantly undergo latent infection, whereas treat-
ment with sodium butyrate increases the proportion of cells
undergoing lytic infection (Renne et al. 1996). We gener-
ated small RNA libraries from both treated and untreated
BCBL-1 cells. Immunofluorescent and flow cytometric ana-
lyses of sodium butyrate-treated cells for the viral protein
K8.1 confirmed an enrichment of cells undergoing lytic
infection (data not shown). Total RNA was harvested from
each population of cells (treated and untreated), and RNAs
in the size range of z16–70 nt were isolated. Appropriate
linkers were added, and after reverse transcription, the
cDNAs were sequenced on a 454 pyrophosphate sequencer
(see G Hannon, ‘‘Cloning small RNAs for sequencing
with 454 technology,’’ http://genoseq.ucla.edu/images/a/a9/
SmallRNA.pdf). We obtained a combined total of approx-
imately 250,000 reads for the 454 analysis of the BCBL-1
cells (z0.43% mapping to KSHV genome) (Supplemental
Table S1) and approximately 98 million reads from SOLiD
sequencing of the TREx BCBL-RTA cells (z5% mapping to
the KSHV genome) (Table 1). Because of the significantly
greater depth attained by the SOLiD analysis, much of this
paper utilizes these data, but several findings are buttressed
by the 454 analysis (see below).
We filtered the results to identify those reads mapping
to the KSHV genome. Plotting the fraction of SOLiD reads
that were 19–23 nt in length relative to the reads in the
larger size class (z45–75 nt) revealed a single region of the
genome greatly enriched for miRNA/siRNA-sized RNAs
(Fig. 2A,B). Notably, this part of the genome (nucleotide
positions 117,780–122,161), encodes the previously de-
scribed KSHV polycistronic miRNA cluster. The vast major-
ity of the reads in this region are in the same orientation
as the KSHV miRNAs. We can detect distinct start sites of
the 5p and 3p miRNAs for all 12 KSHV pre-miRNA loci
(Supplemental Fig. S1; discussed below). This result vali-
dates the ability of our approach to detect viral miRNAs
from cells undergoing latent or lytic infection. Near iden-
tical results were obtained (albeit with much less coverage)
when the 454 data were analyzed in a similar manner (Sup-
plemental Fig. S2). Combined, these data suggest that
no other regions of the KSHV genome encode miRNAs
FIGURE 1. Experimental strategy employed. (A) Two different sizes of small RNAs, 18–25 nt, enriched for miRNAs, and 45–75 nt, enriched for
pre-miRNAs, were size-fractionated by denaturing polyacrylamide gel electrophoresis, ligated to linkers, and then converted to cDNA. After
amplification, the cDNAs were sequenced by ABI SOLiD. Computational methods were used to map reads corresponding to the KSHV genome
(NC_009333.1), and (B) the desired size class (19–23 nt) was plotted over other sizes present in the library to determine regions of the genome
enriched for specific classes of small RNAs (hypothetical plot shown). (C) Western immunoblot analysis demonstrating induction of markers for
lytic replication with various drug regimens for 48 h. The TREx–RTA BCBL-1 cells are highly inducible for initiation of lytic replication upon
treatment with TPA, Ionomycin (ION), and Doxycyclin (DOX) (T.I.D., treatment with all three drugs). KapB, RTA, and K8.1 correspond to
KSHV proteins that are known to be induced during lytic replication. (Control) Loading control, a >80-kDa band that cross-reacts with the anti-
K8.1 antibody. (D) Northern blot analysis shows that the Polyadenylated Noncoding RNA (PAN), a lytic-specific transcript, is robustly induced
when treated with triple drug regimen (T.I.D.) for 48 h. (E) Flow cytometric analysis shows the percent of individual cells expressing RTA or the
late lytic protein K8.1. The dark line indicates cells treated with the triple drug regimen, T.I.D.
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expressed to the same level as the previously described
polycistronic miRNA cluster.
Cloning of the KSHV pre-miRNAs and all
the derivative 5p and 3p miRNAs
Previous studies have identified 12 KSHV pre-miRNAs
(Cai et al. 2005; Pfeffer et al. 2005; Samols et al. 2005;
Grundhoff et al. 2006) that give rise to
at least 17 different derivative miRNAs
(Griffiths-Jones 2006). We mined our
SOLiD sequencing data to address three
questions: (1) Can we clone the pre-
miRNAs that give rise to the known
KSHV miRNAs? (2) Can we define the
5p and 3p derivatives of all the KSHV
pre-miRNAs? (3) Are any previously
missed KSHV miRNA derivatives likely
to be biologically active?
To our knowledge, previous studies
have not attempted to systematically
clone the pre-miRNAs represented in a
population of viral-infected cells. We
used computational analysis to identify
the amplicons present in our larger size
class library (45–75 nt) that map to
known human or KSHV pre-miRNA
loci (Table 2; data not shown). We next
mapped derivative pre-miRNA (from the
large uninduced [LU] or large induced
[LI] for lytic replication) and miRNA
reads (from the short uninduced [SU]
or short induced [SI] for lytic replica-
tion onto individual, specific miRBase-
annotated pre-miRNA sequence posi-
tions) (Fig. 3; Supplemental Fig. S4).
This analysis identified the KSHV pre-
miRNA for 10 of the 12 known pre-
miRNAs (Fig. 3; Supplemental Fig. S4). Interestingly, some
of the KSHV pre-miRNAs were significantly more abun-
dant than others, but pre-miRNA abundance did not
necessarily correlate with miRNA abundance (Figs. 3, 4;
Supplemental Fig. S4). Of note, the pre-miR-K12-5 was the
fourth most abundant KSHV pre-miRNA that was cloned
despite the fact that its derivative miRNAs are among
the lowest KSHV miRNAs represented in our library. This
TABLE 1. The mapping results from the ABI small RNA analysis pipeline (v0.5)
Incoming
sample
ID
Total
raw
reads
Quality
filtered
reads
Reads
matching
filter
(tRNA/rRNA)
Total
reads
matching
human
precursors
Total
reads
matching
KSHV
precursors
Total
remaining
reads
matching
human
genome
Total
remaining
reads
matching
KSHV
genome
SU 26,475,161 26,326,498 0.31% 14.54% 4.41% 30.34% 0.02%
SI 23,500,864 23,369,502 0.69% 10.39% 5.53% 27.63% 0.08%
LU 33,231,616 33,047,349 1.66% 0.17% 0.16% 33.89% 0.10%
LI 16,125,329 16,036,849 5.80% 0.29% 0.25% 30.85% 0.60%
Reads matching tRNA and rRNA are indicated. The remaining reads were then mapped to known KSHV and human pre-miRNAS. Any
remaining reads were then mapped to the human and KSHV genomes (NCBI36 and EMBL NC_009333.1, respectively). (SU) The ‘‘small’’
uninduced library; (SI) the ‘‘small’’ induced (for lytic replication) library; (LU) the ‘‘large’’ uninduced library; (LI) the ‘‘large’’ induced (for lytic
replication) library. miRNAs are enriched in the small libraries, whereas pre-miRNAs are enriched in the ’’large’’ libraries.
FIGURE 2. Plotting the ratio of 19–23-nt RNAs over other size classes mapping to the KSHV
genome identifies regions enriched for small RNAs of interest. (A) Uninduced. (B) Induced.
(C) Uninduced, 1003 zoom on y-axis. (D) Induced, 1003 zoom on y-axis. RNA libraries from
the uninduced (A,C) or lytic-induced (B,D) RNA were analyzed. (A,B) Low-resolution view
demonstrates the extreme enrichment of reads mapping to the KSHV pre-miRNA loci (labeled
‘‘f ’’). (C,D) Zooming in reveals additional regions enriched for 19–23-nt RNAs (a–e, g).
Window analysis of reads that mapped to the KSHV genome was plotted using a window length
of 500 nt (W = 500; see Materials and Methods section for more details). Regions with a greater
number of short reads than long reads marked ‘‘a–f ’’ were selected for further analysis. Arrows at
the side of plots indicate the orientation of reads that are plotted (rightward arrows indicate top
strand transcripts, leftward-facing arrows indicate the bottom strand transcripts).
Lin et al.
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observation is consistent with previous reports showing
that the pre-miRNA for the BCBL-1-encoded miR-K12-5 is
inefficiently processed into miRNAs (Gottwein et al. 2006).
For both viral and human pre-miRNAs, the 59 end of the
most abundant pre-miRNA amplicons was almost always
co-terminal with the 59 end of the derivative 5p miRNA.
Consistent with the current Microprocessor model (Seitz
and Zamore 2006), these data strongly suggest that process-
ing of the pre-miRNA defines the 59 end of the derivative
5p miRNAs. Thus, pre-miRNAs are ‘‘clonable,’’ and our
45–75-nt libraries (LU and LI) contain pre-miRNAs, while
our 19–23-nt libraries (SU and SI) contain derivative 5p and
3p miRNAs. Consistent with this, our 454 library also con-
tained a small number of pre-miRNAs whose sequences were
represented in their entirety (Supplemental Fig. S3).
Some KSHV ‘‘star’’ miRNAs* are abundant
and biologically active
Typically, each pre-miRNA gives rise to two predominant
products, the 5p and 3p miRNAs, derived from each arm of
the pre-miRNA hairpin. Typically one arm (the ‘‘miRNA
guide strand’’) is favored to be stably incorporated within
RISC and is more abundant than the other arm deriva-
tive. The less abundant derivative, (the ‘‘star miRNA [*]
passenger strand’’) is not typically thought to be the driver
of biological activity. However, unlike most host-derived
miRNAs, several viral pre-miRNAs give rise to abundant 5p
and 3p miRNAs, and at least some viral star miRNAs are
biologically active (Sullivan et al. 2005; Seo et al. 2008). As
previously mentioned, KSHV is known to encode 17 de-
rivative miRNAs from 12 pre-miRNAs. We searched our
libraries to determine if any previously unannotated KSHV
miRNA sequences are represented. All 25 5p and 3p deriv-
atives (including the single edited miRNA) were cloned
and mapped in our libraries (Fig. 3; Table 2; Supplemental
Fig. S4). As expected, many of the miRNA derivatives
represented in our libraries that previously escaped detec-
tion are of low abundance and are presumably * sequences
(miRs-K12-1-3p, 2-3p, 5-5p, 7-5p, 10-5p, and 11-5p).
Nonetheless, many of the KSHV miRNA* derivatives are
more abundant than some nonstar human miRNAs (data
not shown). Furthermore, most KSHV miRNA derivatives
represented in our libraries are detectable by Northern blot
(Fig. 4). Of note, K12-9-5p was previously annotated as
the star derivative (Griffiths-Jones 2006), but is the more
TABLE 2. The mature microRNAs derived from the 12 previously described KSHV pre-miRNAs
kshv miRNA Sequence Length SU SI LU LI
kshv-miR-K12-1-5p ATTACAGGAAACTGGGTGTAAGCT 24 41,787 19,936 18 1
kshv-miR-K12-1-3p GCAGCACCTGTTTCCTGCAACC 22 1973 870 0 0
kshv-miR-K12-2-5p AACTGTAGTCCGGGTCGATCTG 22 30,923 18,161 108 42
kshv-miR-K12-2-3p AGATCTTCCAGGGCTAGAGCT 21 197 107 0 0
kshv-miR-K12-3-5p TCACATTCTGAGGACGGCAGCGA 23 40,886 7939 1 1
kshv-miR-K12-3-3p TCGCGGTCACAGAATGTGACA 21 273 347 0 0
kshv-miR-K12-4-5p AGCTAAACCGCAGTACTCTAGG 22 14,558 36,700 20 2
kshv-miR-K12-4-3p TAGAATACTGAGGCCTAGCTGA 22 5874 2669 0 0
kshv-miR-K12-5-5p TAGGTAGTCCCTGGTGCCCTAA 22 128 147 308 8
kshv-miR-K12-5-3p TAGGATGCCTGGAACTTGCCGGT 23 6702 1313 0 0
kshv-miR-K12-6-5p CCAGCAGCACCTAATCCATCGG 22 12,036 3575 0 0
kshv-miR-K12-6-3p TGATGGTTTTCGGGCTGTTGAG 22 116,089 1981 0 5
kshv-miR-K12-7-5p AGCGCCACCGGACGGGGATTTA 22 259 26 30 2
kshv-miR-K12-7-3p TGATCCCATGTTGCTGGCGCTC 22 23,523 9378 0 4
kshv-miR-K12-8-5p ACTCCCTCACTAACGCCCCGC 21 1392 8262 399 131
kshv-miR-K12-8-3p CTAGGCGCGACTGAGAGAGCA 21 8680 15,216 0 1
kshv-miR-K12-9-5p ACCCAGCTGCGTAAACCCCGC 21 11,547 3805 1 0
kshv-miR-K12-9-3p CTGGGTATACGCAGCTGCGTA 21 1507 3285 0 0
kshv-miR-K12-10-5p GGCTTGGGGCGATACCACCACT 22 1246 3843 2448 8115
kshv-miR-K12-10a/b-3p T(A/G)GTGTTGTCCCCCCGAGTGG 21 15,873 67,463 0 4
kshv-miR-K12-11-5p GGTCACAGCTTAAACATTTCT 21 494 112 549 50
kshv-miR-K12-11-3p TTAATGCTTAGCCTGTGTCCGA 22 6342 4068 0 3
kshv-miR-K12-12-5p AACCAGGCCACCATTCCTCTCC 22 4318 6423 19 20
kshv-miR-K12-12-3p TGGGGGAGGGTGCCCTGGTTGA 22 562 7634 0 1
Total length-filtered reads mapping to KSHV mature miRNA 347,169 223,260 3901 8390
Total length-filtered reads mapping to KSHV mature miRNA + HSA mature miRNA 1,775,832 1,160,074 6097 9475
These counts were obtained by mapping reads to the KSHV precursors (miRBase version 13.0, gff-version 2), filtering for matches with three or
less mismatches, and filtering by length (SU and SI: 18–25 nt; LU and LI: $30 nt). The sequences and lengths for the mature miRNAs were
extrapolated from the KSHV pre-miRNA by taking into account the genomic coordinates to which the largest number of reads (either SU or SI)
mapped and the mean lengths of the matches. Note, the 3p miRNAs rarely score in the LU or LI libraries because the SOLiD reads cut off at 35
nt (thus, reads of pre-miRNAs will encompass the 5p miRNAs but not the 3p miRNAs). The SU, SI, LU, and LI labels are described in the legend
to Table 1.
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abundant amplicon represented in our libraries and is
robustly detectable by Northern blot analysis (Fig. 4; Table
2). Interestingly, both K12-8-5p and K12-12-3p had pre-
viously escaped detection but are extremely abundant in
our libraries and robustly detectable by Northern blot ana-
lysis (Figs. 4, 5; Table 2). Combined, these data argue that
some KSHV miRNA derivatives that were previously un-
reported are abundant and might have biological activity.
To test whether K12-12-3p could have biological activity,
we constructed luciferase reporters that have binding sites
complementary to either the 5p or 3p K12-12 derivatives,
or negative control reporters with mutations in the region
complementary to the miRNA seed. Transfection of an ir-
relevant construct encoding miR-K12-4 had little effect on
luciferase activity from either the K12-5p and 3p reporters
or the negative control reporters (Fig. 5C; data not shown).
FIGURE 3. Read coverage of four exemplary KSHV miRNAs and pre-miRNAs. Reads were mapped to a position on the miRBase-annotated
hairpins. Note: The miRBase-annotated hairpins are longer than the actual pre-miRNA hairpins that are ‘‘liberated’’ by microprocessor cleavage.
Pre-miRs-K12-8 and 12 both express abundant 5p and 3p derivative miRNAs that were missed in previous studies. Pre-miRs-K12-5, 10a, and 12
have flanking moRNAs. The ‘‘x’’ axis indicates the nucleotide position relative to the predicted longer hairpin precursor that is listed in miRBase.
The ‘‘y’’ axis indicates the quantity of reads for a particular pre-miRNA derivative and is plotted on a log scale to show lower-abundance
derivatives. The horizontal lines (green, red, blue, black) indicate the nucleotide position coverage of a particular read. The four vertical lines
denote the start site and end site of the 5p and 3p miRNAs. (SU) The ‘‘small’’ RNA library (19–24 nt) from uninduced cells; (SI) the ‘‘small’’ RNA
library from cells induced to initiate lytic replication; (LU) the ‘‘large’’ RNA library (45–75 nt) from uninduced cells; (LI) the ‘‘large’’ RNA library
from cells induced to initiate lytic replication. The reads corresponding to the pre-miRNAs (LU, LI) have a maximum length of 35 nt (the upper
cut-off of read length available from the current SOLiD platform). Reads corresponding to moRNAs are indicated with text above the relevant
horizontal lines.
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However, transfection of a vector encoding the K12-12 pre-
miRNA reduced luciferase expression from both reporter
vectors by z50%. An additional negative control experi-
ment, whereby the construct encoding the K12-12 pre-
miRNA was transfected with an irrelevant luciferase re-
porter containing binding sites to the JCV viral miRNA
(Seo et al. 2008), showed no effect on luciferase activity
(data not shown). Combined, these data argue that the
effects of the K12-12 5p and 3p miRNAs are specific. How-
ever, we note that until bona fide mRNA targets are
identified, the relative activity of K12-12 5p and 3p dur-
ing infection is uncertain. Thus, the K12-12-3p miRNA is
abundant and likely active in KSHV-infected cells.
Discovery of a viral-encoded moRNA
moRNAs are derived from the extreme ends of pre-miRNA
loci, and in mammalian cells, are typically of significantly
lower abundance than the miRNA derivatives (Langenberger
et al. 2009; Shi et al. 2009). So far, moRNAs have not been
reported to be encoded by viruses. Most of the KSHV pre-
miRNA loci (11 out of 12) did not show abundant read
patterns indicative of moRNAs (Fig. 5D; Supplemental Figs.
S1, S4). However, a clear exception was pre-miR-K12-12
(Fig. 5D). As is typical for most of the KSHV pre-miRNAs,
the histogram of reads covering the pre-miR-K12-12 locus
shows distinct peaks for the 5p and 3p derivative miRNAs.
Additionally, a small peak, consistent with a moRNA de-
rivative, is evident at the 39 end of pre-miR-K12-12 (Fig.
5D). The number of reads corresponding to the moRNA
was relatively few, around 100 total reads. This number is
at the lower end of what we observe for
the host miRNAs that are represented in
our libraries, and much lower than the
K12-5p and 3p miRNAs (consistent with
the low processing efficiencies reported
for other mammalian-derived moRNAs)
(Langenberger et al. 2009). Repeated at-
tempts to express this moRNA using the
plasmid construct that expresses pre-
miR-K12 (and miRNA derivatives) failed
to demonstrate a moRNA-corresponding
band via Northern blot analysis (data
not shown). This suggests that the K12
moRNA is very inefficiently processed
and/or not amenable to exogenous ex-
pression and raises the possibility that
moRNAs are nonfunctional miRNA pro-
cessing intermediates. Finally,wenote that
pre-miR-K12-4, 5, 6, and 10 also contain
reads consistent with 39 or 59 moRNAs
(Fig. 3; Supplemental Fig. S4). We con-
clude that KSHV encodes multiple, albeit
low-abundance, moRNAs.
Discovery of KSHV antisense miRNAs expressed
during lytic replication
From our earlier size ratio analysis (Fig. 2A,B), it was clear
that no regions of the KSHV genome encoded miRNAs as
abundant as the previously described polycistronic miRNA
cluster. To explore the possibility that less abundant RNAi-
associated RNAs (miRNA/siRNAs) may be expressed dur-
ing infection, we altered the scale of our previous analysis
to include regions of the genome that showed only slight
enrichment in 19–23-nt RNAs over other size classes (Fig.
2C,D). As before, 19–23-nt RNAs from the smaller library
were compared with other size classes (45–75 nt, from the
larger library). At this scale, a general trend across the KSHV
genome is evident, whereby most regions are enriched for
the non-miRNA-size classes (45–75-nt RNAs). We do not
detect regions of the genome that are enriched for 19–23-nt
RNAs in both the sense and antisense orientations—that
would be indicative of siRNAs. We therefore conclude it is
unlikely that abundant siRNAs derived from longer antisense
dsRNAs are robustly made during KSHV lytic infection.
During lytic replication, seven regions of the genome
show peaks where 19–23-nt RNAs of a single orientation
are over-represented during lytic infection (Fig. 2D, ‘‘a–g’’).
We applied an additional filter to weed out potentially ar-
tifactual peaks that required each region to also be enriched
for 19–23-nt RNAs over >24-nt RNAs present in the small
library (another filter for random degradation fragments).
This added filter removed region ‘‘e’’ from further consid-
eration. Peak ‘‘f’’ is readily accounted for as the KSHV
latent miRNA cluster. Of the remaining peaks, only ‘‘d’’ and
FIGURE 4. Northern blot analysis of KSHV-encoded miRNAs demonstrates that the 5p and
3p miRNAs are detectable from most KSHV pre-miRNA loci. For a few pre-miRNAs, only one
strand was detectable as an miRNA (pre-miR-K12-1, 2, 4, and 6). For the others, the miRNAs
were abundant enough that we could detect both the 5p and 3p derivatives. The left lanes (U)
correspond to RNA from untreated cells (predominantly latent), the right lanes (I) correspond
to RNA from induced cells enriched for lytic replication. Arrows indicate miRNAs migrating
at z22 nt. The loading control, shown in bottom panels, is ethidium bromide-stained low-
molecular-weight RNA.
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‘‘g’’ had read patterns that were consistent with miRNAs
(reads mapping of the appropriate miRNA size and confined
to one or a few 59 and 39 termini). Peaks ‘‘a–c’’ will be
addressed in the Discussion section. Peak ‘‘d’’ maps to the
coding region of ORF 45. Northern blot analysis for this
region was inconsistent (data not shown), and the flanking
regions of this peak are not predicted to fold into a pre-
miRNA-like structure (data not shown). Therefore, we aban-
doned further experiments in this region of the genome.
Peak ‘‘g’’ is notable because it encompasses a predomi-
nantly 22-nt RNA that maps antisense to miR-K12-4-5p
(Fig. 6A). This fact caught our attention since previous
reports have identified antisense miRNAs in other herpes-
viruses (Buck et al. 2007; Dolken et al. 2007; Umbach et al.
2008). As this putative miRNA differs from miR-K12-4-3p
by only 6 nt (Fig. 6B), we examined whether there was any
preference for sequencing errors in these six residues that
would be suggestive of misannotation due to a computa-
tional artifact. We observed no preference for mismatches
at these particular six nucleotides (data not shown), sug-
gesting that the reads corresponding to the AS-miRNA are
not simply sequencing errors of miR-K-12-4-3p. Next, we
predicted the secondary structure of transcripts from this
region. A hairpin secondary structure is predicted antisense
to pre-miR-K12-4 (Fig. 6A). The location of the AS-miRNA
maps to a position on the predicted hairpin precursor that
is completely consistent with pre-miRNA structure and de-
rivative miRNA processing (Fig. 6A). To determine if tran-
scripts that span this region could be efficiently processed
into miRNAs, we subcloned the portion of the genome
corresponding to the predicted pre-miRNA hairpin and
flanking regions (z200 bp in total) into a heterologous
expression vector. We transfected the vector and harvested
total RNA. Northern blot analysis confirmed robust and
specific processing of this miRNA (Fig. 6C). We then
assayed whether this miRNA has biological activity within
the RISC complex. A reporter containing perfectly com-
plementary binding sites, or a negative control reporter
containing 5-nt point mutations (complementary to the
seed region) was co-transfected with the miRNA-expressing
vector. Luciferase assays conducted on lysates harvested from
these cells demonstrate robust and specific knockdown of
FIGURE 5. Multiple specific small RNAs derived from pre-miR-K12. (A) Predicted secondary structure of pre-miR-K12-12. The two derivative
miRNAs, K12-12-5p (Griffiths-Jones 2006) and K12-12-3p (reported in this study), are indicated with black bars. The K12-12 moRNA is
indicated with a gray bar. (B) Northern blot analysis of miR-K12-12 5p and miR-K12-12-3p. Two models of lytic induction were analyzed. RNA
from regular BCBL-1 cells that were predominantly undergoing latent infection (untreated) or treated with sodium butyrate (NaB) to induce lytic
replication was used. RNA from the nonisogenic, uninfected KSHV-negative BJAB cells serves as a negative control. Additionally, RNA from
untreated, predominantly latent, or triple drug-treated T.I.D. (lytic-enriched) TREx-RTA BCBL-1 cells was analyzed. Arrows indicate miRNA
band. (C) Luciferase assay demonstrates that both miRNA derivatives of pre-miR-K12-12 are active. Renilla luciferase reporter vector with four
copies of miR-K12-12-5p or miR-K12-12-3p target sites were co-transfected with the pre-miR-K12-4 or pre-miR-K12-12 expression vectors. As
a negative control, an identical reporter containing mutations in the seed complementary region was also analyzed. A normalization vector (firefly
luciferase vector) was also co-transfected as a control for transfection efficiency. (D) Histogram of read coverage from the small induced (18–25,
SI) library shows the relative abundance of miR-K12-12-5p, miR-K12-12-3p, and K-12 moRNA. 3p derivative miRNAs correspond to the left
peak; 5p derivative miRNAs correspond to right peak. A histogram of reads mapping to pre-miR-K12-3 is shown for comparison.
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the target reporter (Fig. 6D). These data show that driving
transcription of this region of the genome leads to efficient
processing of a pre-miRNA and biological activity of the
derivative miRNA within RISC. We conclude that this is
a bona fide, low-expressed, lytic-replication-specific miRNA.
Accordingly, we name this miRNA ‘‘miR-K12-4-AS.’’
We next asked whether other KSHV pre-miRNA loci
might encode AS-miRNAs. Three additional KSHV AS-
miRNAs were identified—two from the 5p or 3p arms of
the same AS-pre-miRNA, pre-miR-K12-2-AS (Supplemen-
tal Fig. S5). We named these for the KSHV miRNA loci
they are encoded complementary to: ‘‘K12-8-AS-5p,’’ ‘‘K12-
2-AS-5p,’’ and ‘‘K12-2-AS-3p.’’ We also uncovered reads
for at least one AS-pre-miRNA, pre-miR-K12-8, comple-
mentary to miR-K-12-8 (Supplemental Fig. S5). These re-
sults are satisfying because they strongly imply that similar
to host miRNAs, the KS AS-miRNAs are derived via normal
Microprocessor/Dicer miRNA machinery processing.
Small RNA profiling reveals transcripts throughout
the genome originating from both the bottom
and top strands
The discovery of KSHV AS-miRNAs is noteworthy since it
implies the existence of previously unknown longer pre-
cursor transcripts that are encoded antisense and comple-
mentary to the KSHV miRNA cluster. To determine if such
transcripts exist, we turned to a coverage plot, whereby
all the transcripts represented in our libraries were plotted
in the bottom or top strand orientations (Fig. 7A). Most of
the reads we observe from the latently infected cells cor-
respond to the KSHV miRNA cluster (Fig. 7A). Since much
of the genome is only transcriptionally active during lytic
replication, it was not surprising to observe a dramatic in-
crease in the number of reads obtained from cells under-
going lytic replication (Fig. 7A). Presumably, many of these
are random degradation fragments of larger transcripts.
Strikingly, during lytic replication, we observe antisense
transcription in regions spanning almost the entire ge-
nome. This includes the regions of the genome that encode
the latent transcripts and the latent miRNA cluster, which
previously were not known to encode antisense transcripts.
To confirm that antisense transcription occurs in many
regions of the genome, we used directional reverse tran-
scription, followed by PCR. Ten regions of the genome
were chosen that were only known to encode transcripts
of a single orientation (Supplemental Fig. S6; data not
shown). Additionally, for a positive control, we included
a region of the genome encompassing a portion of ORF50/
RTA known to encode bottom and top strand transcripts
(Lukac et al. 1999; Saveliev et al. 2002). Directional RT-
PCR confirmed that eight of these regions (including the
ORF50/RTA control) encode detectable sense and antisense
transcripts during lytic replication (Fig. 7B). Those regions
that scored positive for antisense transcription had to meet
several criteria: first, there had to be a distinct band of
the appropriate size in cells undergoing lytic replication;
second, there had to be no band detectable from several
different negative controls including: RNA harvested from
lytic cells in which RT was omitted from the reaction, RNA
harvested from uninfected cells (BJAB) that were treated
with the same induction drug regimen, and RNA from cells
undergoing lytic replication that was primed with any of 10
different irrelevant RT primers from alternative regions of
FIGURE 6. Expression and activity of an antisense miRNA complementary to the pre-miR-K12-4 locus. (A) Predicted secondary structure of
the pre-miR-K12-4 and pre-miR-K12-4-AS. Mapped 5p derivative miRNAs are indicated with a black bar; mapped 3p derivative miRNAs
are indicated with a gray bar. (B) Sequences of miR-K12-4 and miR-K12-4-AS. Nucleotide differences between K12-4-3p and K12-4-AS-3p are
indicated in bold/underline. (C) Northern blot analysis of miR-K12-4-AS. Cells were transfected with a vector expressing either miR-K12-10 or
miR-K12-4-AS. RNA was harvested and hybridized with a probe complementary to miR-K12-4-AS. Arrow indicates miRNA band. (D) miR-K12-
4-AS is active within the RISC complex. Expression of a plasmid expressing miR-K12-4-AS down-regulates expression of a reporter containing
complementary binding sites, but not a control reporter in which the seed complementary region is mutated.
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the KSHV genome (Supplemental Fig. S6). Importantly,
directional RT-PCR confirmed that the miRNA cluster
region of the genome not only undergoes robust transcrip-
tion in the same orientation as the miRNAs, but also
detectable transcription antisense to the latent KSHV miR-
NAs (Fig. 7B). Thus, by several criteria, unknown transcripts
FIGURE 7. (Legend on next page)
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exist that are antisense to the KSHV miRNA cluster that
could give rise to the AS-pre-miRNAs. Furthermore, lytic
replication produces numerous previously unknown tran-
scripts that are antisense to the abundant, previously charac-
terized KSHV transcripts.
DISCUSSION
Identification of previously undescribed abundant
miRNA derivatives
In this study, we utilized two different methods to generate
our small RNA libraries and sequenced each by either the
454 or SOLiD sequencing techniques. Sequencing at this
depth, we were able to identify eight new derivative miRNAs
encompassing all 25 derivatives that are known or would
be predicted to be encoded by the previously reported 12
KSHV pre-miRNAs (Table 2). Notably, based on Northern
blot analysis and relative amplicon numbers, two of the
previously unreported KS miRNAs represented in our librar-
ies, K12-8-5p and K12-12-3p, are highly abundant (Figs. 4, 5;
Table 2). At present, we do not understand why miR-K12-
8-5p has escaped previous detection. miR-K12-12-3p con-
tains a BAN I restriction site that was used in the studies
that identified 11 of the 12 abundant KSHV pre-miRNAs
and derivatives (Cai et al. 2005; Pfeffer et al. 2005; Samols
et al. 2005). Therefore, miRK-12-12-3p was likely dropped
out of the libraries during the cloning procedures. Pre-
viously, miR-K12-12-5p was uniquely identified by an ap-
proach that relied on computational prediction, followed
by scoring positive on a custommicroarray and then North-
ern blot analysis (Grundhoff et al. 2006). Because miR-
K12-12-3p is a particularly GC-rich miRNA, it was filtered
out as part of the pipeline of microarray analysis utilized in
this study; therefore, it was not discovered at that time by
Northern blot analysis (Grundhoff et al. 2006). In our
present study, miR-K12-12-3p is more abundant or at least
as abundant as miR-K12-12-5p (Fig. 5B), is fully functional
in RISC (Fig. 5C), and may be an important driver of the
biological activity associated with this pre-miRNA. What is
the function of miR-K12-12-3p? Currently, its function is
unknown, but it is notable that the pre-miR-K12-12 and
pre-miR-K12-10 derivatives are the only viral miRNAs
expressed at noticeably increased levels during lytic activa-
tion (Figs. 4, 5B; Cai et al. 2005). These data are consistent
with both miRNAs being encoded within the body of the
Kaposin transcripts that are up-regulated by RTA trans-
activation during lytic replication (Sadler et al. 1999; Chang
et al. 2002). These observations point to a likely impor-
tant role during lytic replication or perhaps even a role
during the initial times of de novo infection (if these
miRNAs are somehow packaged within the virion). Future
studies are required to determine the relevant functions
of pre-miR-K12-10 and pre-miR-K12-12 derivatives and
whether they target viral or host transcripts during KSHV
infection.
Other KSHV miRNAs did not display robust changes in
the relative amplicons that were consistent between both
the 5p and 3p derivatives (Table 2). However, Northern blot
analysis clearly demonstrated that some KSHV miRNAs show
slightly increased or decreased levels during lytic replication
(Fig. 4). Examining host miRNAs that were differentially
represented in the SOLiD library by Northern blot analysis
revealed that only slightly more than half of the miRNAs
changed in abundance as would be expected if relative am-
plicon number were reflective of actual abundance (data not
shown). Thus, relative amplicon abundance shows a general
trend of congruence but not an absolute or linear correlation
with actual steady-state levels. While some host miRNAs
change in abundance during lytic replication, it remains to be
determined whether these changes are caused by a specific
viral gene product(s), the host innate antiviral response, or
rather, represent a bystander effect of the drug regimen used
to induce the lytic cycle (or the associated stress of lytic
replication). Because of the possible cloning and sequencing
biases that may exist between different libraries (Linsen et al.
2009), we take these combined results to mean that changes
in relative amplicon number between different libraries rep-
resent only a starting point for identifying bona fide changes
in miRNA steady-state levels.
Systematic cloning of viral and host pre-miRNAs
provides insight into general miRNA processing
Because our experimental strategy profiles a range of RNA
size classes, we were able to clone and map the 59 ends
of numerous pre-miRNAs. Using the high-quality-filtered
SOLiD data, we were able to identify 10 of the 12 KSHV
FIGURE 7. Antisense transcription is detected throughout the KSHV genome. (A) Coverage plot of all reads mapping to the KSHV genome.
Sequenced frequency of reads that mapped to the KSHV genome for the combined short and long fractions of uninduced and induced samples is
plotted on a log10 scale on the ‘‘y’’ axis. The ‘‘x’’ axis shows KSHV genomic position. Each graph is divided into top strand transcripts (top,
rightward arrow) and bottom strand transcripts (bottom, leftward arrow) as indicated on the right side of the figure. Locations of confirmatory
directional RT-PCR products are indicated with a small bar/line below the genome map (positions 5041–5252; 12,283–12,496; 25,831–26,039;
73,712–73,929; 87,182–87,451; 104,671–104,880; 121,579–121,820; 123,061–123,269). Genome annotations are based on NCBI reference sequence
NC_009333.1. (B) Directional RT-PCR confirms existence of previously unreported antisense transcription during KSHV lytic infection. A
positive control known to have antisense transcription (ORF50; 73,712–73,929) or seven regions previously only known to have transcription in
one orientation were tested for antisense transcription. RNA from uninfected BJAB cells was used as a negative control. The orientation of the
strand being primed by the RT primer is indicated at the top of the figure. A ‘‘no RT’’ control was included to exclude the possibility of genomic
DNA contamination. To control for possible false positives due to RT mis-priming, all regions shown scored negative in PCR assays when any of
10 different control RT primers were used (Supplemental Fig. S6).
Small RNA profiling of KSHV lytic infection
www.rnajournal.org 1551
pre-miRNAs (Table 2). Additionally, using less stringent
filters, we were also able to identify the remaining two
KSHV pre-miRNAs in our library (data not shown). We
also cloned and mapped the 59 end of numerous human
host pre-miRNAs (data not shown). Furthermore, despite
the low coverage of our 454 data, we were able to clone and
map the entire transcript (including 59 and 39 ends) of
a few host and viral pre-miRNAs (Supplemental Fig. S3).
Several conclusions can be made from these data. First,
as would be predicted with the Microprocessor model of
miRNA processing (Denli et al. 2004; Gregory et al. 2004;
Chendrimada et al. 2005; Seitz and Zamore 2006), the 59
ends of the pre-miRNAs are almost always co-terminal with
the 59 ends of the 5p miRNAs. Furthermore, our limited in
depth searches into 24 viral and host pre-miRNAs (Fig. 3;
data not shown) did not identify any examples of non-
templated 59 modifications. Combined, these data strongly
suggest that Drosha cleavage, as part of the Microprocessor
complex, determines the final 59 end of most miRNAs. Our
data argue that cloning and profiling of pre-miRNAs are
readily achievable and may be of future use for confirmation
that candidate miRNAs are, indeed, derived from Micro-
processor activity (see discussion below regarding KSHV
AS-miRNAs), or for globally profiling post-transcriptional
regulation of specific primary miRNA transcripts.
A method for identifying regions of a genome
enriched for specific functional classes of RNAs
identifies novel KSHV-encoded small RNAs
We developed an experimental strategy for identifying
genomic regions enriched for RNAs of a particular size
and functional class (Figs. 1A,B, 2). By plotting the ratio of
the size class of interest to other sizes in the library (which
presumably represents mostly degradation fragments of
longer transcripts), we identified a region of the genome
enriched for a novel AS-miRNA (e.g., miR-K12-4-AS)
(Fig. 6; Supplemental Fig. S5). Such an approach may be
particularly useful when dealing with cells undergoing lytic
viral replication, as these discrete transcripts were identified
amidst a sea of random degradation fragment noise caused
by KSHV lytic activation (Fig. 7A). We also identified an
additional low-abundance small RNA, the K12-12 moRNA,
which we believe to be the first viral moRNA to be reported.
Thus, the combination of deep sequencing and size-class
analysis was fruitful for identifying novel KSHV-encoded
small RNAs.
One question that arises is whether the K12-12 moRNA
is the only KSHV-encoded moRNA? In fact, we observe
evidence that pre-miRs-K12-4, 5, 6, and 10 also encode
moRNAs (Fig. 3C; Supplemental Fig. S4D–F,J,L), albeit at
very low abundance. This suggests that additional viral pre-
miRNA loci could be processed into moRNAs at low effi-
ciencies (or that cloning biases excluded them from our
libraries). At present we have no functional understand-
ing of these viral moRNAs, but the seemingly increased
abundance of the K12-12 moRNA suggests this would be
a good starting point for future functional studies.
At present we do not understand why miR-K-12-4-AS is
represented so much more in our library than the other
KSHV AS-miRNAs (>100 reads for miR-K-12-4-AS [on
par with several host-encoded miRNAs] versus <10 reads
for miR-K-12-2-AS-5p, miR-K-12-2-AS-3p, and miR-
K-12-8-AS). There are multiple reasons that could explain
this. First, it is possible that only pre-miR-K12-4 can form
the proper secondary structure to allow efficient miRNA
processing when transcribed from the opposite strand. We
note that the predicted secondary structures of the pre-
miRNAs for the KSHV AS-miRNAs we cloned appear to be
more plausible as Microprocessor substrates than KSHV
AS-pre-miRNA derivatives not represented in our libraries
(with the caveat that predicting Microprocessor/Dicer sub-
strates in silico is highly error-prone) (data not shown). It
is possible that there is a novel promoter upstream of miR-
K-12-4-AS that could allow for transcripts that specifically
encode this pre-miRNA, but this model is not supported by
the close proximity of miR-12-4 to its two closest neigh-
bors, miR-K12-5 (separated by z85 nt) and miR-K12-3
(separated by z60 nt). Additionally, our studies show that
antisense transcripts exist throughout the KSHV latent
miRNA cluster (Fig. 7), making this model less likely. Finally,
it is possible some of the other KSHV loci might encode
more abundant AS-miRNAs, but cloning biases exclude them
from our libraries. Our transfection studies demonstrating
robust expression and activity of the K12-4-AS-miRNA (Fig.
6C,D) argue that the relatively low number of amplicons
we observe during lytic infection is most likely due to a low
amount of transcription of the pri-miRNA. Future experi-
ments will address in detail the biogenesis and functions of
the KSHV AS-miRNAs during lytic infection.
Currently, the functions (if any) of all of these low-
abundance, small KSHV-encoded RNAs are unknown. All
are represented by numerous amplicons and have discrete
ends suggestive of specific processing. Due to our ability to
isolate intermediates in the miRNA biogenesis pathway
(pre-miRNAs and 5p and 3p derivatives of the same pre-
miRNA) (Supplemental Fig. S4), we have high confidence
that the KSHV AS-miRNAs we reported are derived via
specific host miRNA machinery processing. For miR-K-12-
4-AS we furthermore demonstrate biological activity of this
miRNA in an RISC cleavage assay (Fig. 6). The K12-12
moRNA displays the features of other moRNAs (discrete
ends mapping to the termini of pre-miRNA hairpins), so
it is likely that it shares similar processing with the other
known mammalian moRNAs (Langenberger et al. 2009).
At present, we do not have sufficient read depth to make
the same definitive conclusions about the other putative
KSHV moRNAs (K12-4, 5, 6, and 10 moRNAs). Future
studies will address the possible functional relevance of
these RNAs.
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Lytic replication triggers antisense transcription
that is detected at discrete loci throughout
the KSHV genome
Our analysis demonstrated a striking degree of antisense
transcription throughout the entire KSHV genome during
lytic replication (Fig. 7). This observation is perhaps not
surprising, given the precedence set by lytic infection with
other viruses such as adenovirus and human cytomegalo-
virus (Maran and Mathews 1988; Zhang et al. 2007). How-
ever, to our knowledge, this degree of antisense transcrip-
tion has not been previously reported for KSHV. These
transcripts are not reflective of a constant degree of back-
ground transcription that is simply up-regulated during
lytic infection, since the ratio of antisense transcripts ob-
served (and not just absolute abundance) is dramatically
altered during lytic replication (data not shown). Such
prevalent amounts of antisense transcripts have a great
potential to form dsRNAs. These observations may help to
explain why KSHV has evolved numerous countermea-
sures to deal with the cellular interferon immune response
that can be activated by dsRNA (Coscoy 2007; Areste and
Blackbourn 2009; Bisson et al. 2009; Lee et al. 2009). In
addition, these results suggest that the virus will have to
deal with the issue of RNA polymerase exclusion and may,
in fact, use antisense transcription to regulate viral gene
expression. Despite the depth of our libraries and the
success of our methodology for enriching for specific size
classes of small RNAs, we did not detect any strong evi-
dence for the existence of abundant viral siRNAs during
lytic infection. A few regions of the genome expressed
a high ratio of z21-nt RNAs relative to other size classes
that would be expected for siRNAs (including regions
‘‘a’’–‘‘c’’ from Fig. 2D). But these regions mostly en-
code RNAs in the same orientation as the abundant,
annotated, longer transcripts derived from these regions
(in fact, peak ‘‘c’’ encompasses reads mapping in the same
direction as PAN, the most abundant KSHV transcript
made during infection). Thus, our results are not consis-
tent with abundant siRNAs being derived from longer
antisense transcripts. The great majority of the genome is
not enriched for small RNAs of the siRNA size class, and
in the few regions that do contain appropriately sized
RNAs, these RNAs are not of opposing orientations. While
we cannot rule out the possibility that inverted repeat
hairpin formation from single-stranded transcripts leads
to some siRNA generation, sequence gazing in these re-
gions failed to demonstrate likely repeat hairpin precur-
sor structures. Therefore, we conclude that viral-specific
siRNAs during KSHV infection are either (1) not clonable,
(2) of extremely low abundance, or (3) not made. How-
ever, in the absence of performing our studies in Dicer
knockout cells, we cannot rule out with absolute certainty
the possibility that KSHV infection generates low amounts
of siRNAs.
Conclusions
In this study, we have identified eight new derivatives from
the previously described KSHV-pre-miRNAs. Given that
many of these are more abundant than some cellular
miRNAs, it is possible that these newly identified miRNAs
may have functions relevant to viral infection. We also
describe numerous specifically processed small RNAs of
low abundance. One of these, miR-K12-4-AS, represents
a KSHV miRNA that is specifically expressed during lytic
replication and active within the RISC complex. Future
studies are required to determine the functional relevance of
these RNAs. We demonstrate a striking coverage of antisense
transcription throughout the KSHV genome during lytic
replication. These data are represented by small RNAs,
ranging from 18 to 75 nt in size, that span almost every
macroscopic region of the genome. Recently, there has been
much excitement with the realization that a majority of the
mammalian genome is transcribed—including overlapping
sense and antisense transcripts (Maeda et al. 2006; Mattick
and Makunin 2006; Birney et al. 2007). As is true with their
hosts, it is clear that several DNA viruses are also transcribed
in a similar manner. The challenge now is to parse out those
noncoding transcripts that are functionally relevant from
those that are just noise. Given the emerging similarities
between the host and the relatively simpler DNA viral
genomes, it seems that viruses will once again serve as
valuable models for understanding the hosts they infect.
MATERIALS AND METHODS
Cell culture and RNA isolation
BJAB and BCBL-1 (Renne et al. 1996) cells were maintained in
RPMI 1640 medium supplemented with 10% FBS, glutamine, and
b-mercaptoethanol. TREx-RTA BCBL-1 cells (Nakamura et al.
2003) were maintained in DMEM medium supplemented with
20% FBS and Hygromycin B (50 mg/mL). To induce KSHV lytic
replication in BCBL-1 cells, tetradecanoyl phorbol acetate (TPA; final
concentration 20 ng/mL) or sodium butyrate (final concentration
3 mM) was added to the medium 48 h before RNA isolation. To
induce KSHV lytic replication in TREx-RTA BCBL-1, Doxycyclin
(2 mg/mL), TPA (20 ng/mL), and Ionomycin (500 ng/mL) (referred
to as ‘‘T.I.D.’’) were added to the medium (Arias et al. 2009).
Induction of BCBL-1 cells into the lytic cycle was confirmed by flow
cytometric analysis and immunofluorescence microscopy staining
using antibody that recognizes K8.1, a late gene product, as the
marker. Induction of TREx-RTA BCBL-1 cells into the lytic cycle
was confirmed by flow cytometric analysis for RTA and K8.1;
Northern blot analysis for polyadenylated nuclear RNA; andWestern
immunoblot analysis for RTA, K8.1, and Kaposin B. Total RNA was
isolated by using PIG-B solution as described (Weber et al. 1998).
Small RNA library generation and computational
analysis of sequencing reads for 454
Four hundred micrograms of total RNA from uninduced or
sodium butyrate-treated BCBL-1 cells was separated by a 8% urea
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denaturing polyacrylamide gel, and the z16–70-nt band was
excised, crushed, and soaked in 20 mL of 0.3 M NaOAc (pH 5.2)
overnight at 4°C. The supernatants were concentrated via centri-
fugation with the vivaspin 15R concentrator (Sartorius) at 3000g
for z30 min at 4°C. The RNA was then ethanol-precipitated by
adding 100% ethanol and air-dried. The 39 ends of the size-
fractionated RNA were ligated to the linker (59-rAppCTGTAGG
CACCATCAAT/3ddC/-39) using T4 RNA ligase (Ambion) over-
night at 4°C. Ligated RNAs were separated from unincorporated
linkers by a 15% denaturing polyacrylamide gel and extracted as
described (Sullivan and Ganem 2005). The 39 modified RNAs
were then treated with tobacco acid pyrophosphatase (Epicentre)
to remove the cap (if present) on the 59 end, and then ethanol-
precipitated by adding 100% ethanol. An adapter (ACGGAATT
CCTCACTGAG, where RNA nucleosides are underlined) was
ligated to the 59 ends of RNA using T4 RNA ligase (Ambion)
overnight at 4°C. After ethanol precipitation by adding 100%
ethanol, the RNA was reverse-transcribed using the primer ATT
GATGGTGCCTACAG in a 40-mL reaction with 200 units of
SuperScript II reverse transcriptase (Invitrogen) for 1 h at 42°C.
The RT product was PCR-amplified using the forward primer
ACGGAATTCCTCACTGAG and the reverse primer ATTGATG
GTGCCTACAG for 15 cycles and then amplified using the
forward primer GCCTCCCTCGCGCCATCAGACGGAATTCCT
CACTGAG and the reverse primer GCCTTGCCAGCCCGCTCA
GATTGATGGTGCCTACAG for 12 cycles. The PCR samples were
then directly analyzed via 454 deep sequencing (Roche) (Margulies
et al. 2005).
To create a KSHV density maps, the KSHV genome (NC_
009333) was divided into 2000-bp segments, each overlapping
neighboring segments by 1000 bp, to create a BLAST database.
Total sequencing reads were first BLASTed against the KSHV
genome and then size-filtered into 19–23-nt or non-19–23-nt
classes (z16–18-nt and z25–70-nt) based on the number of
nucleotide matches. Each subset was then BLASTed against the
split KSHV genome database. The threshold of the E-value for this
and following BLAST searches was 104. These parameters will
detect sequences with up to 2-nt mismatches. The number of
sequencing reads that matched to each binned genomic segment
was plotted on an XY scatter chart corresponding to the location
in the genome. To check the relative abundance of KSHV
miRNAs, total sequencing reads were first BLASTed against the
KSHV genome, size-filtered into the 19–23-nt class based on the
number of nucleotide matches, and then BLASTed against all
miRBase-annotated (Griffiths-Jones 2006) KSHV-miRNAs. To
check the relative abundance of cellular miRNAs, 18–25-nt se-
quencing reads were BLASTed against the human pre-miRNA
database acquired from miRBase. Thus, the number of reads listed
for a particular cellular miRNA (Supplemental Table S1) encom-
passes both the 5p and 3p miRNAs derived from that pre-miRNA.
Small RNA library generation and computational
analysis of sequencing reads for SOLiD
Three hundred fifty micrograms of total RNA from uninduced or
T.I.D.-treated TREx-RTA BCBL-1 cells was separated by a 15%
urea denaturing polyacrylamide gel, and thez18–25-nt andz45–
75-nt size ranges were excised according to the RNA size markers,
crushed, and soaked in 30 mL of 1 M NaCl overnight at 4°C. The
supernatants were concentrated via centrifugation with the
Vivaspin 15R concentrator (Sartorius) at 3000g for z30 min at
4°C. The RNA was then ethanol-precipitated by adding 100%
ethanol and air-dried. The four RNA populations were then
dissolved and converted into cDNA libraries suitable for SOLiD
sequencing using a commercially available kit (Small RNA Ex-
pression Kit; Ambion). Briefly, degenerate double-stranded sticky-
end adapters were ligated to the single-stranded RNA, with 59- and
39-specific adapters, distinguished by sequence, so RNA sequence
orientation can be determined upon sequencing. The RNA was
reverse-transcribed and treated with RNase H, and fragments of the
appropriate length were selected by PAGE. An additional barcode
sequence was appended to the 39 end of these single-stranded
cDNAs via PCR of these RNase H–treated samples with primers
complementary to the 59 and 39 adapters. A final agarose gel puri-
fication was performed to isolate full-length library product. During
library construction, the location of gel excisions was adjusted to
account for the longer 45–70-nt population.
ABI SOLiD sequencing was performed according to the
manufacturer’s instructions on the SOLiD version 3.0 instrument
and associated protocols. Quantitative PCR was used to measure
each barcoded cDNA library, which were then pooled in equi-
molar amounts. Emulsion PCR was performed on this pool
according to the manufacturer’s instructions to generate beads
ready for deposition and sequencing on the ABI SOLiD. The five
base barcodes of each sequencing bead were read first, followed by
35 bases of the corresponding cDNA sequence. Software provided
by ABI and custom Perl scripts were used to separate the reads
based on their barcode sequences and discard any reads with eight
or more bases with a quality value of less than 8, resulting in the
number of reads shown in Table 1.
The reads for each sample were then processed by the small
RNA analysis pipeline (v0.5) available at solidsoftwaretools.org.
Briefly, this pipeline (1) removed reads matching human ribo-
somal or tRNA and reads containing no template; (2) matched
each read to the known human and KS microRNA precursor
regions in the human and KSHV genomes (NCBI36 and EMBL
U75698.1, respectively, as annotated by the Sanger miRBase
version 13.0, gff-version 2) wherein the match starts with a short
seed and progressively maps until finding the adapter sequence;
and (3) matched all remaining reads to the human and KS
genomes (NCBI36 and NC_009333.1, respectively). Reads not
falling within the expected size ranges (18–24 nt for small RNA,
>30 nt for large RNA) were removed from further analysis to
minimize artifacts from degradation, low sequence quality, or
inaccurate mapping. Custom Perl scripts were then used to
extract start site and length information for each read and to
extract mature miRNA counts from the mappings to miRBase
precursors.
Read size class analysis
Two size classes were defined as small (19–23 nt) from short
fractions and large (45–75 nt) from long fractions. The number of
mapped reads of each size class was summed in a sliding window
of size W nucleotides across the genome in 1-nt increments.
Windows with less than 20 short reads or less than 1 long read
were discarded. The value for each window was then computed
as the number of small reads divided by the number of large
reads.
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Western immunoblot analysis
Cells were lysed with RIPA buffer (0.1% SDS, 1% Triton X-100,
1% deoxycholate, 5 mM EDTA, 150 mM NaCl, and 10 mM Tris at
pH 7.2). Fifty micrograms of the total lysate was separated in 12%
SDS-polyacrylamide gels and transferred to PVDF membranes
(Millipore). Primary antibodies used in this paper are rabbit anti-
RTA antibody (a gift from Don Ganem, UCSF), rabbit anti-
Kaposin B antibody (a gift from Craig McCormick, UCSF), and
mouse anti-ORF K8.1 A/B antibody (Advanced Biotechnologies,
Inc.). Blots were probed with a 1:1000 of primary antibody in 5%
dehydrated milk in Tris Buffered Saline (TBS) and 1:3000 dilution
for the HRP-conjugated secondary antibodies (Invitrogen). Blots
were washed in TBS multiple times, incubated with chemilumi-
nescent substrate (SuperSignal West Pico; Thermo Scientific)
according to the manufacturer’s protocol, and exposed to auto-
radiography film for visualization of bands.
Northern blot analysis
Small RNA Northern blot analysis was performed as described
(Grundhoff et al. 2006). The probe sequences used in this paper
are listed in Supplemental Table S2. Northern blot analysis for
Polyadenylated Noncoding RNA (PAN) was conducted using
total RNA that was separated on a 1% agarose formaldehyde gel
and then transferred using Whatman TurboBlotter Rapid Down-
ward Transfer Systems. Probes and hybridization for PAN were
conducted via an identical strategy used for the small RNA
Northern blot analysis (see Supplemental Table S2).
Flow cytometry
Cells were collected 48 h after mock treatment or treatment with
lytic replication-inducing drugs. Cell were washed with cold PBS
buffer, fixed, and permeabilized with ice-cold 1:1 acetone/meth-
anol for 5 min, and then blocked with 1% BSA containing 13
phosphate-buffered saline (PBS) solution for 10 min. Primary
antibodies against RTA and K8.1 were added to the solution and
incubated for 1 h at room temperature. Cells were washed with
13 PBS buffer three times and stained with Alexa Fluor 488-
conjugated secondary antibodies (Invitrogen). The working con-
centration of primary and secondary antibodies was a 1:1000
dilution. Stained samples were analyzed by flow cytometry with a
FACSCalibur flow cytometer. The data were analyzed with Cell
Pro Software (Becton Dickinson). Dead cells, as determined from
aberrant forward/side scatter, were eliminated from the analysis.
pre-miRNA structure prediction
Secondary structures of pre-miRNAs were predicted by the Mfold
RNA folding prediction web server (Mathews et al. 1999; Zuker
2003).
Vector construction, transfection,
and luciferase assay
The pcDNA3.1-pre-miR-K12-10, pcDNA3.1-pre-miR-K12-12,
pcDNA3.1-pre-miR-K12-4, and pcDNA3.1-pre-miR-K12-4-AS
expression vectors were made by cloning an z200-bp fragment
with the entire pre-miRNA hairpin and flanking regions into the
pcDNA3.1 vector. The miR-K12-12-5p reporter, miR-K12-12-3p
reporter, and miR-K12-4-AS-3p reporter were made by cloning
four copies of the complementary sequences of the miRNAs into
the pcDNA3.1dsRluc vector (Seo et al. 2008). The seed-region-
mutated reporters contain engineered point mutations from the
second nucleotide to the sixth nucleotide complementary to the 59
end of the relevant miRNA. The primers used for cloning are listed
in Supplemental Table S2. All sequences were confirmed by
Sanger sequencing. 293T cells were plated in 12-well plates and
transfected with Lipofectamine 2000 reagent (Invitrogen). Cells
were transfected with miRNA expression vectors along with the
reporter. The pcDNA3.1Luc2CP vector was also co-transfected as
a control for transfection efficiency. Cells were collected 48 h after
transfection and analyzed with the Dual-Glo Luciferase Assay
System (Promega) according to the manufacturer’s instructions.
The luciferase assays were read on a Lumioskan Ascent lumi-
nometer (Thermo Electronic Cooperation). Results for the miRNA
reporters are presented with the Renilla luciferase levels normal-
ized by firefly luciferase levels.
Directional RT-PCR
The total RNA from BJAB or induced TREx-RTA BCBL-1 cells was
treated with Turbo DNase (Ambion) according to the manufac-
turer’s instructions. Three hundred nanograms of DNase-treated
RNA was reverse-transcribed to cDNA with avian myeloblastosis
virus (AMV) reverse transcriptase (Finnzymes) using specific RT
primers for 50 min at 64°C and for 10 min at 60°C. One-twentieth
of the RT product was used for PCR amplification using specific
primers and analyzed by agarose gel electrophoresis. No RT control
was included to confirm that the bands detected were not due to
contaminating DNA. All the RT primers and PCR primers are listed
in Supplemental Table S2.
SUPPLEMENTAL MATERIAL
Supplemental material can be found at http://www.rnajournal.org.
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manuscript was under review, in agreement with our results,
Umbach and Cullen (2010) detected sequencing reads consistent
with KSHV-encoded moRNAs and AS-miRNAs.
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